Validation of an assay for determination of anti-xa activity of Rivaroxaban

被引：0
|
作者：
Delavenne, X. [1 ]
Meuley, R. [1 ]
Baylot, D. [2 ]
Mismetti, P. [1 ]
机构：
[1] Univ Hosp St Etienne, St Etienne, France
[2] Clin Mutualiste, St Etienne, France
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：965 / 966
页数：2
相关论文
共 50 条
  • [1] Validation of rivaroxaban anti-Xa activity measurement
    Rathbun, S.
    Tafur, A. J.
    Mauer, K.
    Gausman, J.
    Marlar, R. A.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 964 - 965
  • [2] Universal anti-Xa assay for rivaroxaban and apixaban plasma concentration
    Studt, Jan-Dirk
    Stein, Philipp
    Hegemann, Inga
    Koch, Karin
    Sangalli-Baruffaldi, Jessica
    Nagler, Michael
    [J]. SWISS MEDICAL WEEKLY, 2018, 148 : 37S - 37S
  • [3] Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels
    Studt, J. -D.
    Alberio, L.
    Angelillo-Scherrer, A.
    Asmis, L. M.
    Fontana, P.
    Korte, W.
    Mendez, A.
    Schmid, P.
    Stricker, H.
    Tsakiris, D. A.
    Wuillemin, W. A.
    Nagler, M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (08) : 1576 - 1583
  • [4] A universal anti-Xa assay for rivaroxaban, apixaban, and edoxaban measurements: method validation, diagnostic accuracy and external validation
    Willekens, Guido
    Studt, Jan-Dirk
    Mendez, Adriana
    Alberio, Lorenzo
    Fontana, Pierre
    Wuillemin, Walter A.
    Schmidt, Adrian
    Graf, Lukas
    Gerber, Bernhard
    Bovet, Cedric
    Sauter, Thomas C.
    Nagler, Michael
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (06) : 1203 - 1212
  • [5] Comparison of apixaban and rivaroxaban trough anti-Xa activity.
    Bookstaver, David
    Sparks, Kimberly
    Pybus, Brandon
    Davis, Dustin
    [J]. PHARMACOTHERAPY, 2016, 36 (12): : E239 - E239
  • [6] LABORATORY VALIDATION OF A CHROMOGENIC ANTI-XA ASSAY FOR APIXABAN
    Leger, Rachel R.
    Tange, Julie I.
    McBane, Robert D.
    Chen, Dong
    Pruthi, Rajiv K.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E36 - E37
  • [7] Comparison of Anti-Xa Activity in Patients Receiving Apixaban or Rivaroxaban
    Bookstaver, David A.
    Sparks, Kimberly
    Pybus, Brandon S.
    Davis, Dustin K.
    Marcsisin, Sean R.
    Sousa, Jason C.
    [J]. ANNALS OF PHARMACOTHERAPY, 2018, 52 (03) : 251 - 256
  • [8] Technochrom anti-Xa and technoview rivaroxaban - evaluation of assay performance on different analyzers
    Wagner, L.
    Kaufmann, V
    Mager, J.
    Geiter, S.
    Leitner, M.
    Siegemund, A.
    Lindhoff-Last, E.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 21 - 21
  • [9] ANTI-XA ASSAY FOR MEASUREMENT OF PLASMA RIVAROXABAN IS NOT AFFECTED BY THE ADDITION OF EXOGENOUS ANTITHROMBIN
    Bozic-Mijovski, M.
    Malovrh, P.
    [J]. THROMBOSIS RESEARCH, 2014, 133 : S85 - S86
  • [10] Evaluation of assay performance monitoring Rivaroxaban with TECHNOCHROM anti-Xa on different analyzers
    Leitner, M.
    Kaufmann, V.
    Mager, J.
    Geiter, S.
    Siegemund, A.
    Wagner, L.
    [J]. THROMBOSIS RESEARCH, 2012, 129 : S187 - S187
12345